The update comes almost a month after the first human case was reported. The brain chip is designed to help people with spinal cord injuries.
“Progress is good, [and the] patient seems to have made a full recovery … and is able to control the mouse, move the mouse around the screen just by thinking,” Elon Musk, owner of Neuralink, said in an X Spaces event.
The implant got FDA approval for human trials in May, and recruitment for human trials began in September.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
